Zolmitriptan ODT 2.5 mg (Zolmitriptan TABLET (ORALLY DISINTEGRATING)) 2.5 MG

Zolmitriptan ODT 2.5 mg is an orally disintegrating tablet used for migraine relief. This fast-dissolving form offers convenience and quick absorption. Learn more about its uses and effects.

Strength

2.5 MG

Pack Size

Manufacturer / TM Owner

SANIS HEALTH INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Zolmitriptan ODT 2.5 mg is primarily used for the acute treatment of migraines with or without aura in adults. It works by narrowing blood vessels around the brain, which can help relieve migraine headaches. This medication is designed to dissolve quickly in the mouth, making it easier to take without water. Many people wonder, 'What is Zolmitriptan used for?' and the answer is typically for migraine relief.

Side Effects

Common effects of Zolmitriptan ODT 2.5 mg may include dizziness, dry mouth, and fatigue. Some users report sensations of tingling or warmth. These effects vary and are not experienced by everyone. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Zolmitriptan ODT 2.5 mg should be handled with care, especially by individuals with a history of heart disease or high blood pressure. It is important to follow the guidance of a healthcare professional regarding its use. Keep this medication out of reach of children and store it as directed.

Avoid Interactions

Zolmitriptan ODT 2.5 mg may interact with certain medications, including other migraine treatments, antidepressants, and drugs that affect liver enzymes. Alcohol consumption should be avoided while taking this medication. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

Zolmitriptan ODT 2.5 mg is used for the acute treatment of migraines with or without aura in adults.

Zolmitriptan ODT works by narrowing blood vessels around the brain, which can help relieve migraine headaches.

Common side effects may include dizziness, dry mouth, and fatigue. These effects vary and are not experienced by everyone.

Zolmitriptan ODT may interact with certain medications, so it's important to consult a healthcare provider before combining it with other drugs.

Zolmitriptan ODT should be used with caution, especially by individuals with a history of heart disease or high blood pressure.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.